The pathogenesis of the diabetes-induced motility disorders has been linked to the decrease in ICC, extrinsic and intrinsic neuropathy, and decrease in nNOS expression and activity [18–27]. The gene discussed is NOS1; the disease is intrahepatic cholangiocarcinoma.